EXPEDITION

Showing 1 posts of 1 posts found.

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012
Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …

The Gateway to Local Adoption Series

Latest content